Overview

Study of Proton Therapy in Adjuvant Pancreatic Cancer

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This trial aims to determine a safe schedule of short-course proton beam radiation therapy with adjuvant mFOLFIRINOX for patients with resected pancreatic adenocarcinoma.
Phase:
Phase 1
Details
Lead Sponsor:
Georgetown University